Abstract
We have attempted finding common sequential patterns among protein antigens. For this, we have used Gibbs multiple motif sampler on the set of all non-redundant antigenic sequences available in curated databanks. Several sequential motifs are obtained on these sequences when the amino acids are represented according to their similarity clusters. Significantly high proportions of known B-cell epitope sites are found within or adjacent to these motifs, thus indicating a possibility of linear epitope signatures. These findings may offer important applications in synthesis of peptide vaccines. A predictive example in this regard is presented.
Protein & Peptide Letters
Title: Gibbs Sampling Shows Possibilities of B-Cell Epitope Signatures
Volume: 16 Issue: 11
Author(s): Rajani R. Joshi, Upal Hira and Divyanshu Suri
Affiliation:
Abstract: We have attempted finding common sequential patterns among protein antigens. For this, we have used Gibbs multiple motif sampler on the set of all non-redundant antigenic sequences available in curated databanks. Several sequential motifs are obtained on these sequences when the amino acids are represented according to their similarity clusters. Significantly high proportions of known B-cell epitope sites are found within or adjacent to these motifs, thus indicating a possibility of linear epitope signatures. These findings may offer important applications in synthesis of peptide vaccines. A predictive example in this regard is presented.
Export Options
About this article
Cite this article as:
Joshi R. Rajani, Hira Upal and Suri Divyanshu, Gibbs Sampling Shows Possibilities of B-Cell Epitope Signatures, Protein & Peptide Letters 2009; 16 (11) . https://dx.doi.org/10.2174/092986609789353664
DOI https://dx.doi.org/10.2174/092986609789353664 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases
Current Immunology Reviews (Discontinued) Carbon Monoxide and the Brain: Time to Rethink the Dogma
Current Pharmaceutical Design Natural Killer Cells Adjudicate Every Stage of Anti-Viral Immune Response
Current Immunology Reviews (Discontinued) The New Immunosuppression: Intervention at the Dendritic Cell-T-Cell Interface
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Potential and Perspectives of Cyclonucleosides
Current Medicinal Chemistry Improving DNA Vaccine Performance Through Vector Design
Current Gene Therapy Gene Targeting and Expression Modulation by Peptide Nucleic Acids (PNA)
Current Pharmaceutical Design The Endocannabinoid System and Multiple Sclerosis
Current Pharmaceutical Design Brain Inflammation is a Common Feature of HIV-Infected Patients without HIV Encephalitis or Productive Brain Infection
Current HIV Research Acyclovir in the Treatment of Herpes Viruses – A Review
Current Medicinal Chemistry Intrinsic Disorder and Function of the HIV-1 Tat Protein
Protein & Peptide Letters Astrocytes: Implications for Neuroinflammatory Pathogenesis of Alzheimers Disease
Current Alzheimer Research Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets The Role of Amyloid-Beta Derived Diffusible Ligands (ADDLs) in Alzheimers Disease
Current Topics in Medicinal Chemistry Jembrana Disease Virus: Host Responses, Viral Dynamics and Disease Control
Current HIV Research HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System
Current HIV Research Synthesis and Biological Evaluation of a Series of 4-(arylamido/imidoalkyl)- 5-(arylideno- 4-oxo-2-thio-imidazolidinyl)-N-(methyl-phenyl-imino) Acridinium Iodides as Potential Antiviral Agents
Letters in Drug Design & Discovery Animal Models of Systemic Sclerosis
Current Pharmaceutical Design Perspectives in Genomics The Future of Fungi in ‘omics’ era
Current Genomics Inactivated- or Killed-Virus HIV/AIDS Vaccines
Current Drug Targets - Infectious Disorders